Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH
Author(s) -
Juan Balasch,
Francisco Fábregues,
Joana Peñarrubia,
Francisco Carmona,
Roser Casamitjana,
Montserrat Creus,
Dolors Manau,
Gemma Casals,
Juan A. Vanrell
Publication year - 2006
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/del052
Subject(s) - basal (medicine) , follicular phase , testosterone (patch) , transdermal , medicine , pregnancy rate , gonadotropin , stimulation , follicle stimulating hormone , endocrinology , pregnancy , infertility , andrology , biology , luteinizing hormone , hormone , pharmacology , insulin , genetics
Treatment of poor-responder patients to controlled ovarian stimulation for assisted reproduction, who have normal basal FSH concentrations, is one of the most difficult challenges in reproductive medicine. This study investigated the usefulness of testosterone pretreatment in such patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom